EquityZen Thematic Fund LLC - Future of Health Series 1
Raised
$1M
Investors
99
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Thematic Fund LLC - Future of Health Series 1 is a Delaware pooled investment fund filed by EquityZen Advisors LLC and related parties, raising $1.3M from 99 investors under Rule 506(b) and Section 3(c)(1) exemptions with a $10K minimum investment. This amended filing is part of EquityZen's platform, which operates approximately 150 related EDGAR entities focused on private equity investments.
This filing represents a typical mid-sized private equity pooled fund structure using the 506(b) exemption combined with 3(c)(1), limiting it to 99 accredited investors. The $10K minimum investment is notably accessible compared to most private equity vehicles, which typically require $50K-$250K minimums, reflecting EquityZen's platform model of democratizing access to pre-IPO equity.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
